Orchestra BioMed Holdings (OBIO) Change in Acquisitions & Divestments (2023 - 2025)
Orchestra BioMed Holdings (OBIO) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $8.0 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 53.85% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.9 million through Dec 2025, down 42.44% year-over-year, with the annual reading at $49.9 million for FY2025, 42.44% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $8.0 million at Orchestra BioMed Holdings, down from $9.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $51.5 million in Q3 2023, with the low at $8.0 million in Q4 2025.
- Average Change in Acquisitions & Divestments over 3 years is $22.5 million, with a median of $16.8 million recorded in 2024.
- The sharpest move saw Change in Acquisitions & Divestments plummeted 79.39% in 2024, then fell 10.42% in 2025.
- Over 3 years, Change in Acquisitions & Divestments stood at $37.1 million in 2023, then tumbled by 53.57% to $17.2 million in 2024, then plummeted by 53.85% to $8.0 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $8.0 million, $9.5 million, and $16.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.